Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
about
Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomesA novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansCancer immunoediting from immune surveillance to immune escapeNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyNKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple MyelomaNKG2D Ligands in Tumor Immunity: Two Sides of a CoinA transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2DTransfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.An six-amino acid motif in the alpha3 domain of MICA is the cancer therapeutic target to inhibit sheddingPerturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis.Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.MICB0106 gene polymorphism is associated with ulcerative colitis in central China.Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseRegulation of ligands for the NKG2D activating receptor.The tumor microenvironment in colorectal carcinogenesis.Oncogenic stress sensed by the immune system: role of natural killer cell receptorsRecognition of tumors by the innate immune system and natural killer cells.Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion.The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions.Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy.Two opposing roles of O-glycans in tumor metastasis.Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells.NKG2D in NK and T cell-mediated immunity.NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cellsAbnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer.Cancer and pregnancy share similar mechanisms of immunological escape.Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.Review article: immune suppression and colorectal cancer.Models to Study NK Cell Biology and Possible Clinical Application.The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.Human natural killer cells.
P2860
Q24294847-08AFA8F3-2B4F-466A-9EF3-342323FB507BQ24308236-AE7D8BC7-8C63-412C-A4A9-A2CE61ED5799Q24655415-306E1770-54EE-405D-9563-F239CDFB3E8FQ26773135-71BD2622-B43C-41FF-AC73-D9B7C32D958CQ27008625-E633380B-B4EE-4358-9D1A-7791B1BB928FQ28080823-1A63498F-D5C7-4B1D-873F-8906C6DCD061Q28083832-F52B53A7-6EED-4C14-A385-AA92AE3C3CE9Q28564229-860E6D5A-9C80-46BD-BAA9-CECF3AD01226Q30477811-AB03D222-E3C4-43BB-A23A-20889D702901Q30489974-27779F93-6D84-400E-B0C8-09D6BCBB8F24Q30547087-08A57E35-32E5-46D1-884A-F0CF6A4444E6Q33315601-D0D58947-E558-4834-A0A7-90C61ACF1502Q33555680-FB44B2B4-DCF0-4503-9BC1-FF200BB81053Q33577921-E34E59F1-98D5-4CF2-A48F-B15C3FFE8C93Q33898809-A0DCDC05-0336-4A95-BC4C-2171AC0F49EBQ33914699-31072E5E-0FC3-41FA-A038-54C2055340D6Q34016504-7053F56A-B0E8-41FA-AB49-B80457609F79Q34068134-1875A46B-2923-4539-ABE7-A2783AC2435CQ34307792-5D573963-44D9-4843-80C9-13A14E364015Q34321457-7C9DCC91-1E97-41A7-A229-68FEB4F8CA5FQ34343645-30C1AE39-8767-4E22-938E-B807AD055142Q34473267-1A558FCD-A2AD-410A-8A3A-0EA9502843C0Q34496462-26B539E6-E932-4A11-8249-6275B2342A34Q34694955-5CD0FA27-8291-4687-810D-E3AAF5A35914Q35287627-F3A7E1C1-F1E6-4A53-BF6B-81815AFA195DQ35847668-70652EA6-4C29-431F-8037-4BE1AD211C07Q35848101-FA6284A3-DB89-40C7-BBB1-8416D0D1BAF3Q35972468-35CD2C73-025F-4BB2-A05C-4706783EF691Q36110266-C5E52B82-1988-44C9-A35D-307A140B5889Q36354709-EC6CF6AD-612A-44C9-9EB0-30F3D1E8A356Q36399548-E58B78D6-70F0-4380-9A55-8F1ED40EFF7CQ36403637-093552B4-B14B-40D7-8D3D-B3D84AE272F3Q36407095-8452EA7B-94DE-4A16-8757-2DC558B9B1A2Q36412775-962E4AEF-D426-4C67-A1D1-CE3A14D0E075Q36447939-7656685B-F3E5-4BE0-99A4-F509810D2C25Q36473179-B81A15EA-3F72-46A8-B6EF-2D8B49B219F1Q36609898-4F212AEC-5CDA-4398-B431-2B43B1FD5D93Q36635914-8D30EC93-EDE4-443A-9265-42EF923D9F2EQ36652214-DF31184F-3736-4BAF-BD51-9E377B62F24DQ36787596-3A331C78-7A1E-47DC-9A80-B61BE22366AB
P2860
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Evasion from NK cell immunity ...... pressing colon adenocarcinoma.
@en
type
label
Evasion from NK cell immunity ...... pressing colon adenocarcinoma.
@en
prefLabel
Evasion from NK cell immunity ...... pressing colon adenocarcinoma.
@en
P2093
P1476
Evasion from NK cell immunity ...... xpressing colon adenocarcinoma
@en
P2093
Ekaterina S Doubrovina
Elena Vider
Mikhail M Doubrovin
Richard B Sisson
Richard J O'Reilly
P304
P356
10.4049/JIMMUNOL.171.12.6891
P407
P577
2003-12-01T00:00:00Z